Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026

Bulletin Express

03/20

Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.

The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.

Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.

Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.

Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1111826406"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111826406\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111826406?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111826406","market":"hk","top_or_hot":-1,"title":"Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.</p>\n<p>The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.</p>\n<p>Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.</p>\n<p>Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.</p>\n<p>Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-20 18:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.</p>\n<p>The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.</p>\n<p>Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.</p>\n<p>Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.</p>\n<p>Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君實生物","start_time":0,"source_url":"","article_id":"1111826406","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111826406","pubTimestamp":1774002196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物(01877/688180)定于2026年3月27日举行2025年度业绩说明会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.\nThe company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.\nKey management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.\nInvestors can submit questions in advance through the 「Pre-collection of Questions」 section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.\nFurther details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}